Novartis AG - 23 Year Stock Price History | NVS

Historical daily share price chart and data for Novartis AG since 1996 adjusted for splits. The latest closing stock price for Novartis AG as of October 14, 2019 is 85.93.
  • The all-time high Novartis AG stock closing price was 106.12 on July 20, 2015.
  • The Novartis AG 52-week high stock price is 96.31, which is 12.1% above the current share price.
  • The Novartis AG 52-week low stock price is 74.97, which is 12.8% below the current share price.
  • The average Novartis AG stock price for the last 52 weeks is 88.00.
Novartis AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 88.1801 84.0600 96.1400 75.4000 85.9300 0.14%
2018 82.7945 84.6800 93.9100 72.4400 85.8100 2.20%
2017 80.5118 72.8300 86.6500 70.0300 83.9600 15.27%
2016 76.7115 85.7500 86.2100 67.5900 72.8400 -15.34%
2015 97.2964 92.2500 106.1200 83.9600 86.0400 -7.14%
2014 88.0541 78.7200 96.6500 78.2000 92.6600 15.28%
2013 73.0721 63.8300 80.3900 63.7000 80.3800 26.98%
2012 57.5083 58.1800 63.9600 51.4800 63.3000 10.72%
2011 57.3696 59.2400 64.5200 51.6500 57.1700 -3.02%
2010 53.0627 52.6100 59.7700 43.7800 58.9500 8.30%
2009 44.6554 49.5400 56.1600 33.9600 54.4300 9.39%
2008 51.5838 54.5700 61.0600 43.8500 49.7600 -8.38%
2007 55.5306 58.1400 59.7000 51.6000 54.3100 -5.45%
2006 56.3869 53.4700 61.2400 51.9000 57.4400 9.45%
2005 49.6493 50.2700 54.7000 45.7500 52.4800 3.84%
2004 45.9760 45.9000 50.6200 41.3000 50.5400 10.13%
2003 39.0642 37.1000 45.8900 34.5400 45.8900 24.94%
2002 39.0227 35.7900 43.8300 34.1000 36.7300 0.63%
2001 38.2865 44.8100 45.0000 32.9800 36.5000 -18.44%
2000 37.0009 36.3750 44.7500 29.9400 44.7500 22.18%
1999 39.3345 51.7500 52.2500 34.9350 36.6250 -25.26%
1998 42.7576 41.1850 50.3750 36.1250 49.0000 20.44%
1997 35.4474 28.5650 42.2500 27.3150 40.6850 41.51%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $198.470B $51.900B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.602B 15.10
Roche Holding AG (RHHBY) Switzerland $247.573B 0.00
Merck (MRK) United States $215.942B 17.76
Pfizer (PFE) United States $199.726B 11.76
Novo Nordisk (NVO) Denmark $121.313B 21.43
AstraZeneca (AZN) United Kingdom $114.344B 22.12
Sanofi (SNY) France $112.561B 13.83
AbbVie (ABBV) United States $108.861B 8.72
GlaxoSmithKline (GSK) United Kingdom $105.206B 13.22
Eli Lilly (LLY) United States $104.614B 19.52
Bristol-Myers Squibb (BMY) United States $84.422B 11.97
Bayer (BAYRY) Germany $66.771B 9.73
H Lundbeck (HLUYY) Denmark $6.541B 9.44